Skip to content
  • Sunday, 26 July 2026
  • 6:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases
Pharmaceutical R&D

Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases

Teuku Ryan Jun 27, 2026 0

Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…

Read More
Laboratory Automation & Robotics

Top pharma companies set sustainability goals, but emissions are still increasing

Lana Keisha Jun 26, 2026 0

The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…

Read More
Pharmaceutical R&D

US Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma Competitors

Teuku Ryan Jun 25, 2026 0

San Diego, CA – The landscape of global biopharmaceutical innovation is undergoing a significant shift, with concerns mounting among investors…

Read More
Pharmaceutical R&D

Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care

Teuku Ryan Jun 25, 2026 0

The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…

Read More
Laboratory Automation & Robotics

Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma

Lana Keisha Jun 24, 2026 0

Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…

Read More
Pharmaceutical R&D

Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets

Teuku Ryan Jun 24, 2026 0

In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…

Read More
Pharmaceutical R&D

The Future of Cell and Gene Therapy Manufacturing is Being Revolutionized by AI and Advanced Data Strategies

Teuku Ryan Jun 24, 2026 0

San Diego, CA – The complex landscape of cell and gene therapy manufacturing, a field consistently challenged by the transition…

Read More
Pharmaceutical R&D

NVIDIA Unveils BioNeMo Agent Toolkit to Accelerate Life Sciences R&D with AI

Teuku Ryan Jun 24, 2026 0

San Diego, CA – NVIDIA has officially launched the BioNeMo agent toolkit, a groundbreaking suite of tools specifically engineered to…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 23, 2026 0

Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…

Read More
Pharmaceutical R&D

The Crucial Role of Data Reliability in Early-Phase Clinical Trials for Pharmaceutical Development

Teuku Ryan Jun 23, 2026 0

In the intricate landscape of pharmaceutical research and development, the integrity of data generated during early-phase clinical trials serves as…

Read More

Posts pagination

1 … 5 6 7 … 39
AI could uncover new physics faster but there’s a surprising catchTWiV 1288: Clinical update with Dr. Daniel GriffinDaily Habits in Midlife Offer Powerful Predictions of Lifespan in Groundbreaking Fish StudyUnraveling the Molecular Choreography of Bacterial Cell Division: UAB Scientists Reveal MraZ’s Dynamic Role in Orchestrating Growth
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ